NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

癌症臨床決策支援工具的全球市場 (2020-2030年) :COVID-19造成的成長與變化

Cancer Clinical Decision Tools Global Market Report 2020-30: COVID-19 Growth and Change

出版商 The Business Research Company 商品編碼 975746
出版日期 按訂單生產 內容資訊 英文 200 Pages
商品交期: 2-10個工作天內
價格
癌症臨床決策支援工具的全球市場 (2020-2030年) :COVID-19造成的成長與變化 Cancer Clinical Decision Tools Global Market Report 2020-30: COVID-19 Growth and Change
出版日期: 按訂單生產內容資訊: 英文 200 Pages
簡介

本報告提供全球癌症臨床決策支援工具市場相關調查分析,提供市場概要,市場規模與預測,各市場區隔的市場分析,各地各國的市場分析,競爭情形等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 癌症臨床決策支援工具市場特徵

第3章 癌症臨床決策支援工具的市場規模·成長率

  • 全球市場的實際成果 (以金額為準)
    • 市場促進因素
    • 市場阻礙因素
  • 全球市場的預測 (以金額為準)
    • 市場促進因素
    • 市場阻礙因素

第4章 癌症臨床決策支援工具市場區隔

  • 世界市場區隔:各類型,實際成果與預測 (以金額為準)
    • 風險評估工具(RAT)
    • Qcancer
  • 世界市場區隔:各終端用戶,實際成果與預測 (以金額為準)
    • 醫院
    • 診所

第5章 癌症臨床決策支援工具市場:各地各國分析

  • 全球市場的區分:各地區,實際成果與預測 (以金額為準)
  • 全球市場的區分:各國,實際成果與預測 (以金額為準)

第6章 亞太地區的癌症臨床決策支援工具市場

  • 市場概要
  • 市場區隔:各類型,實際成果與預測 (以金額為準)
  • 市場區隔:各終端用戶,實際成果與預測 (以金額為準)

第7章 中國的癌症臨床決策支援工具市場

第8章 印度的癌症臨床決策支援工具市場

第9章 日本的癌症臨床決策支援工具市場

第10章 澳洲的癌症臨床決策支援工具市場

第11章 印尼的癌症臨床決策支援工具市場

第12章 韓國的癌症臨床決策支援工具市場

第13章 西歐的癌症臨床決策支援工具市場

第14章 英國的癌症臨床決策支援工具市場

第15章 德國的癌症臨床決策支援工具市場

第16章 法國的癌症臨床決策支援工具市場

第17章 東歐的癌症臨床決策支援工具市場

第18章 俄羅斯的癌症臨床決策支援工具市場

第19章 北美的癌症臨床決策支援工具市場

第20章 美國的癌症臨床決策支援工具市場

第21章 南美的癌症臨床決策支援工具市場

第22章 巴西的癌症臨床決策支援工具市場

第23章 中東的癌症臨床決策支援工具市場

第24章 非洲的癌症臨床決策支援工具市場

第25章 市場競爭情形和企業簡介

  • 競爭情形
  • 企業簡介
    • McKesson Corporation
    • Medical Information Technology Inc.
    • Philips Healthcare
    • Elsevier B.V.
    • Siemens Healthineers

第26章 主要的收購與合併

第27章 市場趨勢與策略

第28章 未來展望和潛在性分析

第29章 附錄

目錄

“Cancer Clinical Decision Tools Global Market Report 2020-30: Covid 19 Growth And Change” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global cancer clinical decision tools market.

This report focuses on cancer clinical decision tools market which is experiencing strong growth. The report gives a guide to the cancer clinical decision tools market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the cancer clinical decision tools? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Cancer Clinical Decision Tools market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider cancer clinical decision tools market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The cancer clinical decision tools market section of the report gives context. It compares the cancer clinical decision tools market with other segments of the cancer clinical decision tools market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, cancer clinical decision tools indicators comparison.

Scope

Markets Covered:

  • 1) By Type: Risk Assessment Tool(RAT); Qcancer
  • 2) By End-User: Hospital; Clinics
  • Companies Mentioned: McKesson Corporation; Medical Information Technology Inc.; Philips Healthcare; Elsevier B.V.; Siemens Healthineers
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series:: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations:: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Cancer Clinical Decision Tools Market Characteristics

3. Cancer Clinical Decision Tools Market Size And Growth

  • 3.1. Global Cancer Clinical Decision Tools Historic Market, 2015 - 2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Cancer Clinical Decision Tools Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Cancer Clinical Decision Tools Market Segmentation

  • 4.1. Global Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Risk Assessment Tool(RAT)
  • Qcancer
  • 4.2. Global Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Hospital
  • Clinics

5. Cancer Clinical Decision Tools Market Regional And Country Analysis

  • 5.1. Global Cancer Clinical Decision Tools Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 5.2. Global Cancer Clinical Decision Tools Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Cancer Clinical Decision Tools Market

  • 6.1. Asia-Pacific Cancer Clinical Decision Tools Market Overview
  • 6.2. Asia-Pacific Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 6.3. Asia-Pacific Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Cancer Clinical Decision Tools Market

  • 7.1. China Cancer Clinical Decision Tools Market Overview
  • 7.2. China Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
  • 7.3. China Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Cancer Clinical Decision Tools Market

  • 8.1. India Cancer Clinical Decision Tools Market Overview
  • 8.2. India Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 8.3. India Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Cancer Clinical Decision Tools Market

  • 9.1. Japan Cancer Clinical Decision Tools Market Overview
  • 9.2. Japan Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 9.3. Japan Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Cancer Clinical Decision Tools Market

  • 10.1. Australia Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 10.2. Australia Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Cancer Clinical Decision Tools Market

  • 11.1. Indonesia Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 11.2. Indonesia Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Cancer Clinical Decision Tools Market

  • 12.1. South Korea Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 12.2. South Korea Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Cancer Clinical Decision Tools Market

  • 13.1. Western Europe Cancer Clinical Decision Tools Market Overview
  • 13.2. Western Europe Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 13.3. Western Europe Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Cancer Clinical Decision Tools Market

  • 14.1. UK Cancer Clinical Decision Tools Market Overview
  • 14.2. UK Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 14.3. UK Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Cancer Clinical Decision Tools Market

  • 15.1. Germany Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 15.2. Germany Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Cancer Clinical Decision Tools Market

  • 16.4. France Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 16.5. France Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Cancer Clinical Decision Tools Market

  • 17.1. Eastern Europe Cancer Clinical Decision Tools Market Overview
  • 17.2. Eastern Europe Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 17.3. Eastern Europe Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Cancer Clinical Decision Tools Market

  • 18.1. Russia Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 18.2. Russia Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Cancer Clinical Decision Tools Market

  • 19.1. North America Cancer Clinical Decision Tools Market Overview
  • 19.2. North America Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 19.3. North America Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Cancer Clinical Decision Tools Market

  • 20.1. USA Cancer Clinical Decision Tools Market Overview
  • 20.2. USA Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 20.3. USA Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Cancer Clinical Decision Tools Market

  • 21.1. South America Cancer Clinical Decision Tools Market Overview
  • 21.2. South America Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 21.3. South America Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Cancer Clinical Decision Tools Market

  • 22.1. Brazil Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 22.2. Brazil Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Cancer Clinical Decision Tools Market

  • 23.1. Middle East Cancer Clinical Decision Tools Market Overview
  • 23.2. Middle East Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 23.3. Middle East Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Cancer Clinical Decision Tools Market

  • 24.1. Africa Cancer Clinical Decision Tools Market Overview
  • 24.2. Africa Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 24.3. Africa Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Cancer Clinical Decision Tools Market Competitive Landscape And Company Profiles

  • 25.1. Cancer Clinical Decision Tools Market Competitive Landscape
  • 25.2. Cancer Clinical Decision Tools Market Company Profiles
    • 25.2.1. McKesson Corporation
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. Medical Information Technology Inc.
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Philips Healthcare
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Elsevier B.V.
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Siemens Healthineers
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Cancer Clinical Decision Tools Market

27. Cancer Clinical Decision Tools Market Trends And Strategies

28. Cancer Clinical Decision Tools Market Future Outlook and Potential Analysis

29. Appendix

  • 29.1. Abbreviations
  • 29.2. Currencies
  • 29.3. Research Inquiries
  • 29.4. The Business Research Company
  • 29.5. Copyright And Disclaimer